Status:
WITHDRAWN
Magnitude of Changes in 25 OH Vitamin D3 Levels After Vitamin D3 Supplementation
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Conditions:
Vitamin D Deficiency
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
PHASE2
Brief Summary
Vitamin D deficiency is common world wide. 25 OH vitamin D level is the best indicator of vitamin D status. The determination of the appropriate dose of vitamin D supplement is essential for managemen...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adults living in Riyadh area who consume no more than one serving of milk/day, do not take vitamin supplement, habitually have less than 10 hr of sun exposure per week, don't suffer from granulomatous conditions, liver disease, or kidney disease, and don't take anticonvulsants, barbiturates, or steroids.
- Individuals with with total 25 OH vitamin D level exceeding 100 nmol/l will be excluded from the study. Individuals with 25 OH vitamin D levels less than 20 nmol/L will be excluded from the placebo arm.
Exclusion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01170507
Start Date
December 1 2011
End Date
August 1 2016
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia, 11211